Navigation Links
Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
Date:1/29/2008

Athletes Using Surgex(TM) can be Assured of No Banned Substances

BASKING RIDGE, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), announced today that Surgex(TM) (http://www.surgexsports.com) has been tested and certified into the Banned Substance Control Group's (BSCG) certification program. This is the only certification program in the US that uses a World Anti Doping Agency accredited laboratory to detect for dangerous banned substances in nutritional supplements. Each batch of Millennium's line of Surgex(TM) products are now tested and certified not to contain substances such as hormones, steroids, stimulants, diuretics, etc that are banned for Professional, Collegiate and Olympic sports. The BSCG certification in addition to the Surgex'(TM) clinical trials should provide the product a competitive advantage upon commercialization into the billion dollar sports nutritional supplement marketplace.

"The athlete can now be assured that our Surgex(TM) line of products can be safely consumed as each batch is tested for a list of substances that are banned by organizations such as the International Olympic Committee (IOC), the World Anti-Doping Agency (WADA), the United States Anti-Doping Agency (USADA), the National Collegiate Athletic Association (NCAA), the National Football League (NFL), and many other professional and amateur sports leagues." states Carl Germano, RD, CNS, CDN, clinical nutritionist and VP of Research & product Development for Millennium Biotechnologies.

With over 5 years in the medical market as a nutritional adjunct to medical care for immuno-compromised conditions and several successful studies including 2 double blind, placebo controlled trials in Division 1 athletes, the Surgex(TM) line of products is breaking new ground for credibility and pro
'/>"/>

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
4. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
7. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 Leading ... to capture critical product and market insights in ... benefits to employee-based studies, it is essential for ... own internal employees to capture critical business-related insights. ... benchmarking firm, Best Practices, LLC, most benchmarked companies ...
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ... common shares have been approved for listing and trading on ... ESSA will begin trading on NASDAQ on July 9, ... Venture Exchange under the symbol "EPI". As a ... NASDAQ, each of the Company,s outstanding special warrants issued on ...
(Date:7/2/2015)... July 2, 2015 ResMed Inc. (NYSE: RMD ... and fiscal year ended June 30, 2015 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... SARcode Bioscience, Inc., a privately-held biopharmaceutical company, ... enrolled in the company,s pivotal Phase 3 clinical ... (Logo: http://photos.prnewswire.com/prnh/20110718/FL36481LOGO) SAR 1118 ... by blocking the binding of two key cellular ...
... response to the growing needs of its clients, Avrio ... Hull 72FXS100-SS25C Freeze Drying System and a new M&O ... Alu-Crimp Capping Machine. The acquisition of these leading-edge technologies ... and Bosch FLT Automated Filling/Stoppering/Capping systems allow Avrio to ...
Cached Medicine Technology:First Patient Enrolled in SARcode Bioscience's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution 2First Patient Enrolled in SARcode Bioscience's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution 3Avrio Purchases a New Lyophilizer and Liquid Vial Filling Machine - New Capabilities and Added Capacity 2
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... ... ... “Negative pressure wound therapy (NPWT) - pipeline review 2015” provides comprehensive information ... stages of development. Complete report on negative pressure wound therapy (NPWT) with ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of New ... a leading international authority on the conservative treatment of back, hip, knee and ...
(Date:7/2/2015)... ... July 02, 2015 , ... Hand sanitizers have become ... summer flu season, according to fresh water advocate and radio host Sharon Kleyne, hand ... Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied correctly and users ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... status of the Gelatin Capsule manufacturers. The report is a valuable source of ... report depicts the global and Chinese market for the Gelatin Capsule industry including ...
(Date:7/2/2015)... ... 2015 , ... As the world becomes more connected through the Internet, not ... products in their everyday lives. Technology can now help homeowners gain more control of ... safety, as well as making kitchen tasks simpler. , "Summer is a ...
Breaking Medicine News(10 mins):Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4
... Wood was Mayo pioneer in aerospace medicineROCHESTER, Minn., March ... investigator credited with inventing the high-altitude pressure suit worn ... Minn. He was 97. "As both a physician and ... leadership to Mayo Clinic and scientific advancements to the ...
... for as Little as 35 CentsSAN CLEMENTE, Calif., March 23 ... forward to every morning. But at about three dollars ... nearly $1100 a year! In these tough economic times, ... reducing their latte consumption, but their calcium intake as well. ...
... La., March 23 Brain Gym(R) provides a simple ... and adults every day; difficulties with reading, writing, math, ... movement. Brain Gym(R) is based on the use ... process for Brain Balance, which can break through cognitive ...
... a debilitating fall. But a University of Illinois at Chicago ... by practicing the Chinese martial art of tai chi. , ... has studied and used tai chi as a way to ... she and a colleague have seen similar results in a ...
... WASHINGTON, March 23 Jesse Buchanan of Minden, NV, ... Tuesday, March 31, 2009 to meet with congressional leaders ... and more research toward a cure for epilepsy.Buchanan, 14, ... country participating in Kids Speak Up! , a ...
... Webcast to Discuss Key Trends Changing the Face of Global Pharma Marketing ... ... Manhattan Research, a global healthcare and pharmaceutical market research company, ... in emerging markets amidst the need for global best practices. The presentation ...
Cached Medicine News:Health News:Inventor of G-Suit Dies 2Health News:Inventor of G-Suit Dies 3Health News:Inventor of G-Suit Dies 4Health News:Boost Your Calcium Consumption - Have a Latte! 2Health News:Boost Your Calcium Consumption - Have a Latte! 3Health News:Learning Empowered by Movement; Brain Gym Exercises Wake Up Brain and Body 2Health News:Stroke survivors improve balance with tai chi 2Health News:Nevada Youth Shares Epilepsy Message On Capitol Hill 2Health News:Manhattan Research: Physician New Media Adoption in Emerging Pharma Markets - Webcast April 3 2Health News:Manhattan Research: Physician New Media Adoption in Emerging Pharma Markets - Webcast April 3 3
... with elastic fabric, these head cap systems ... to begin testing. Each Electro-Cap System features ... International 10-20 System. When you place your ... using with your head cap system and ...
... head cap systems are packaged to provide ... Electro-Cap System features pure tin electrodes positioned ... you place your order, please specify which ... cap system and whether you want regular ...
... OR, ER, or ICU, be sure you take ... Keeping noise low and signal quality high, each ... special shielded cable that insulates the recording lead ... That means you get a cleaner, quieter signaleven ...
... The Bio-eye hydroxyapatite (HA) orbital implant ... in the early 1980s, after a comprehensive ... which included the earliest manuscripts dating back ... with an ongoing dissatisfaction with the performance ...
Medicine Products: